Status: current, Primitive. Date: 31-Mar 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3265081000168110 | Imfinzi (trade product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3265091000168113 | Imfinzi | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Imfinzi | Is a | trade product | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Imfinzi 500 mg/10 mL injection, 10 mL vial | has TP | True | Imfinzi | Inferred relationship | Some | |
| Imfinzi (durvalumab 500 mg / 10 mL) injection, 1 x 10 mL vial (trade product pack) | has TP | True | Imfinzi | Inferred relationship | Some | |
| Imfinzi 120 mg/2.4 mL injection, 2.4 mL vial | Is a | True | Imfinzi | Inferred relationship | Some | |
| Imfinzi 500 mg/10 mL injection, 10 mL vial | Is a | True | Imfinzi | Inferred relationship | Some | |
| Imfinzi 120 mg/2.4 mL injection, 2.4 mL vial | has TP | True | Imfinzi | Inferred relationship | Some | |
| Imfinzi 120 mg/2.4 mL injection, 2.4 mL vial | has TP | True | Imfinzi | Inferred relationship | Some |
Reference Sets
FHIR